ArticleHuman vaccines & immunotherapeutics2026
Adult vaccination coverage and missed preventive care opportunities among Filipino adults with diabetes: A cross-sectional study.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adults with diabetes mellitus are at increased risk of vaccine-preventable infections and complications. Despite recommendations for adult immunization, uptake remains suboptimal in many low- and middle-income countries, including the Philippines, where data remain limited. This cross-sectional study assessed adult immunization coverage and associated clinical and sociodemographic factors among Filipino adults with diabetes recruited from inpatient, outpatient, and community outreach settings at a tertiary hospital. Uptake of influenza, pneumococcal, herpes zoster, hepatitis B, tetanus-diphtheria-pertussis (Td/Tdap), and COVID-19 vaccines was evaluated using prespecified operational definitions. Crude associations and parsimonious multivariable logistic regression models were examined; COVID-19 vaccination was not modeled because only six participants were unvaccinated. Among 284 participants (mean age 61.5 ± 12.7 y, 55.6% females), uptake was 44.4% for influenza, 49.6% for pneumococcal, 18.1% for herpes zoster, 15.5% for hepatitis B, 23.2% for Td/Tdap, and 97.9% for the primary COVID-19 series. Males had lower adjusted odds of influenza and pneumococcal vaccination, while increasing age was associated with pneumococcal uptake. Middle and high household income and diabetes duration of 5-10 y were associated with influenza vaccination. Among adults aged ≥50 y, male sex and high income were associated with herpes zoster vaccination. High income was also associated with hepatitis B and Td/Tdap uptake. Provider recommendation was associated with all outcomes, while lack of provider recommendation, failure to prioritize vaccination, and financial constraints were common reasons for non-vaccination. Uptake was uneven and low for most recommended adult vaccines. Integrating vaccine assessment and counseling into diabetes care while addressing financial and access barriers may improve uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.